FACILITATION OF TUMOUR PROGRESSION BY CANCER THERAPY
- 1 October 1982
- journal article
- point of-view
- Published by Elsevier in The Lancet
- Vol. 320 (8305) , 977-978
- https://doi.org/10.1016/s0140-6736(82)90169-6
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Phenotypic drift of metastatic and cell‐surface properties of mammary adenocarcinoma cell clones during growth in vitroInternational Journal of Cancer, 1981
- Increasing metastatic potential is associated with increasing genetic instability of clones isolated from murine neoplasms.Proceedings of the National Academy of Sciences, 1981
- Interactions among clonal subpopulations affect stability of the metastatic phenotype in polyclonal populations of B16 melanoma cells.Proceedings of the National Academy of Sciences, 1981
- Clonal variation and functional correlation of organ-specific metastasis and an organ-specific metastasis-associated antigenInternational Journal of Cancer, 1981
- Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. II. T lymphocyte-mediated cytolysis.The Journal of Experimental Medicine, 1980
- Teratocarcinoma cell variants rejected by syngeneic mice: protection of mice immunized with these variants against other variants and against the original malignant cell line.Proceedings of the National Academy of Sciences, 1978
- Metastasis Results from Preexisting Variant Cells Within a Malignant TumorScience, 1977
- Rejection by syngeneic mice of cell variants obtained by mutagenesis of a malignant teratocarcinoma cell line.Proceedings of the National Academy of Sciences, 1977
- The Clonal Evolution of Tumor Cell PopulationsScience, 1976
- Repair of potentially lethal radiation damage in mammalian cells is associated with enhancement of malignant transformationNature, 1975